当前位置: X-MOL 学术FEBS Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
15‐Deoxy‐Δ 12,14 ‐prostaglandin J 2 binds and inactivates STAT3 via covalent modification of cysteine 259 in H‐ Ras transformed human breast epithelial cells
FEBS Letters ( IF 3.5 ) Pub Date : 2021-02-08 , DOI: 10.1002/1873-3468.14040
Su-Jung Kim 1 , Nam-Chul Cho 2 , Bitnara Han 3 , Kyeojin Kim 1 , Young-Il Hahn 4 , Kwang Pyo Kim 3, 5 , Young Ger Suh 6 , Bu Young Choi 7 , Hye-Kyung Na 8 , Young-Joon Surh 1, 4, 9
Affiliation  

STAT3 has been considered as a potential target for development of anti-cancer therapeutics. Here, we report a novel mechanism by which the cyclopentenone prostaglandin,15-deoxy-Δ12,14 -prostaglandin J2 (15d-PGJ2 ) functions as an allosteric inhibitor of STAT3. 15d-PGJ2 inhibits phosphorylation, dimerization, nuclear translocation, and transcriptional activity of STAT3 in H-Ras-transformed human mammary epithelial cells (MCF10A-Ras) through the Michael addition reaction at cysteine 259 of STAT3. Comparative studies with 15d-PGJ2 analogues reveal that both C12-C13 and C9-C10 double bonds conjugated to the carbonyl group in the cyclopentenone ring of 15d-PGJ2 are essential for STAT3 binding. Anti-proliferative and pro-apoptotic activities of 15d-PGJ2 in MCF10A-Ras cells are attributable to covalent modification of STAT3 on Cys259, and mimic the effects induced by mutation of this amino acid.

中文翻译:

15-Deoxy-Δ 12,14-前列腺素 J 2 通过 H-Ras 转化的人乳腺上皮细胞中半胱氨酸 259 的共价修饰结合并灭活 STAT3

STAT3 已被认为是开发抗癌疗法的潜在靶点。在这里,我们报告了环戊烯酮前列腺素,15-脱氧-Δ12,14-前列腺素 J2 (15d-PGJ2) 作为 STAT3 变构抑制剂发挥作用的新机制。15d-PGJ2 通过 STAT3 的半胱氨酸 259 的迈克尔加成反应抑制 H-Ras 转化的人乳腺上皮细胞 (MCF10A-Ras) 中 STAT3 的磷酸化、二聚化、核易位和转录活性。与 15d-PGJ2 类似物的比较研究表明,与 15d-PGJ2 环戊烯酮环中的羰基共轭的 C12-C13 和 C9-C10 双键对于 STAT3 结合是必不可少的。MCF10A-Ras 细胞中 15d-PGJ2 的抗增殖和促凋亡活性归因于 Cys259 上 STAT3 的共价修饰,
更新日期:2021-02-08
down
wechat
bug